Sharjah, United Arab Emirates

I El-Gamal Mohammed



Average Co-Inventor Count = 7.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Ventures of El-Gamal Mohammed

Introduction

El-Gamal Mohammed is a notable inventor based in Sharjah, AE, known for his significant contributions to the field of pharmaceuticals. With two active patents, his innovative work focuses on developing effective solutions for cancer treatment.

Latest Patents

Among his key inventions are two significant patents: the imidazooxazole derivative having antitumor effect, and a pharmaceutical composition that includes this derivative. The pharmaceutical composition is designed to prevent and treat tumors by incorporating an imidazooxazole derivative compound, a solvate, a stereoisomer, or a pharmaceutically acceptable salt as the active ingredient. This formulation aims to target entities that have developed tumors or are at risk of developing them, thereby providing a proactive approach to cancer treatment.

Career Highlights

El-Gamal Mohammed is affiliated with the Korea Institute of Science and Technology, where he leverages his expertise in innovative research and development. His focus on antitumor pharmaceuticals reflects his commitment to advancing medical science and improving patient outcomes.

Collaborations

Working alongside esteemed colleagues such as Gamal El-din Mahmoud and Hong Seok Choi, El-Gamal benefits from collaborative efforts that enhance research productivity and foster innovation in cancer therapies. Their collective expertise plays a crucial role in the success of their projects.

Conclusion

El-Gamal Mohammed’s work exemplifies the spirit of innovation in the pharmaceutical industry. With his patents poised to make a difference in cancer treatment, he continues to contribute to the advancement of medical technology and the fight against tumors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…